Difference between revisions of "Meglumine antimonite"

From Dog
Line 1: Line 1:
Meglumine antimonate is a drug used for treatment of canine [[leishmaniasis]].
+
Meglumine antimonate is a pentavalent antimonial drug used for treatment of canine [[leishmaniasis]].
  
Recommended dose rate in dogs is 5 - 30 ml/dog given intravenously or intramuscularly every 48 - 72 hrs.
+
Recommended dose rate in dogs is 5 - 30 ml/dog given subcutaneously or intramuscularly every 48 - 72 hours<ref>Valladares JE ''et al'' (1997) Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. ''Am J Trop Med Hyg'' '''57(4)''':403-406</ref>.
  
 
==References==
 
==References==
 
<References/>
 
<References/>

Revision as of 04:58, 26 April 2013

Meglumine antimonate is a pentavalent antimonial drug used for treatment of canine leishmaniasis.

Recommended dose rate in dogs is 5 - 30 ml/dog given subcutaneously or intramuscularly every 48 - 72 hours[1].

References

  1. Valladares JE et al (1997) Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. Am J Trop Med Hyg 57(4):403-406